To Booster or Not: Scientists and Regulators Debate
To Booster or Not: Scientists and Regulators Debate
President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.
To Booster or Not: Scientists and Regulators Debate
To Booster or Not: Scientists and Regulators Debate

President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.

President Biden’s planned rollout of additional COVID-19 vaccine doses is set to begin next week, but questions remain about who should get them.

SARS-CoV-2
NIH Grants $470 Million for Study of Long COVID
NIH Grants $470 Million for Study of Long COVID
Lisa Winter | Sep 16, 2021
The study aims to recruit 40,000 adults and children to get a better sense of the condition that can last weeks or months after infection.
A Surge in Pandemic Research Shines a Spotlight on Preprints
A Surge in Pandemic Research Shines a Spotlight on Preprints
Diana Kwon | Sep 10, 2021
Many scientists have turned to preprints to rapidly disseminate their research on COVID-19, but some disagree with this approach.
Opinion: An Alternative to Injection
Opinion: An Alternative to Injection
Carmine D’Amico, Hélder Santos | Sep 9, 2021
Research on microneedle patches for vaccine delivery has grown in popularity in recent years, due to their exceptional compliance and low invasiveness.
How Wildfire Smoke Raises Infectious Disease Risk
How Wildfire Smoke Raises Infectious Disease Risk
Amanda Heidt | Sep 8, 2021
As fires blanket growing swathes of the West, scientists are beginning to understand more about how their smoke affects the transmission and severity of COVID-19 and other illnesses, and how it differs from that of other types of air pollution.
Plenty of Evidence for Recombination in SARS-CoV-2
Plenty of Evidence for Recombination in SARS-CoV-2
Abby Olena | Sep 2, 2021
Different variants of the virus behind the COVID-19 pandemic are swapping chunks of genetic material, but it’s not yet clear what implications that may have for public health.
Infographic: The Havoc SARS-CoV-2 Wreaks on the Body
Infographic: The Havoc SARS-CoV-2 Wreaks on the Body
Diana Kwon | Sep 1, 2021
COVID-19 affects far more than just the lungs. Researchers are actively documenting the damage the disease causes to the heart, brain, liver, and much more.
SARS-CoV-2’s Wide-Ranging Effects on the Body
SARS-CoV-2’s Wide-Ranging Effects on the Body
Diana Kwon | Sep 1, 2021
Researchers’ painstaking examinations have begun to reveal how the virus wreaks havoc in multiple organs and tissues.
Infographic: Bodily Systems Affected by Long COVID
Infographic: Bodily Systems Affected by Long COVID
Sruthi S. Balakrishnan | Sep 1, 2021
Symptoms documented in cases of long COVID are wide ranging and variable.
Delta Blues
Delta Blues
Bob Grant | Sep 1, 2021
Humanity was hoping to emerge from the COVID-19 pandemic this year. But viruses have plenty of tools at their disposal, and we should plan for a long-term future in which SARS-CoV-2 is a persistent threat.
Opinion: The Pandemic and the RNA Sequencing Gap
Opinion: The Pandemic and the RNA Sequencing Gap
Robert Ross | Sep 1, 2021
RNA sequencing technology lags far behind researchers’ ability to decode and understand DNA. The COVID-19 pandemic has highlighted this dangerous shortcoming.
Mechanisms of Long COVID Remain Unknown but Data Are Rolling In
Mechanisms of Long COVID Remain Unknown but Data Are Rolling In
Sruthi S. Balakrishnan | Sep 1, 2021
A year and a half into the pandemic, the long-term effects of SARS-CoV-2 infection are garnering more research attention as millions of long COVID patients emerge.
Gut Microbiome May Help or Hinder Defenses Against SARS-CoV-2
Gut Microbiome May Help or Hinder Defenses Against SARS-CoV-2
Bianca Nogrady | Aug 31, 2021
The health of the microbial community is associated with COVID-19 severity, but it’s not yet clear if the relationship is causal.
Immunologist Thomas Hodge Dies of COVID-19 at 69
Immunologist Thomas Hodge Dies of COVID-19 at 69
Lisa Winter | Aug 30, 2021
A former academic and consultant, Hodge cofounded the CrisiScience Collective to help combat the pandemic.